Does inflammation play a role in kava hepatotoxicity?

Phytotherapy Research

Volumn 25, Issue 4, 2011, Pages 629-630

  Zhang, Lillian Yuan ^a   Rowe, Anthony ^a   Ramzan, Iqbal ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

glutathione; hepatotoxicity; inflammation; Kava; metabolites

Indexed keywords

CYCLOOXYGENASE 2; CYTOCHROME P450 2D6; GLUTATHIONE; KAVA EXTRACT;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; CYTOTOXICITY; DISEASE ASSOCIATION; DRUG SAFETY; ENZYME ACTIVITY; ENZYME INHIBITION; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; HEPATITIS; HEPATOBILIARY DISEASE; HUMAN; LIVER TOXICITY; MOLECULAR PATHOLOGY; NONHUMAN; OXIDATIVE STRESS; PHYTOTOXICITY; PLANT ROOT; PROTEIN DEPLETION; SIDE EFFECT; SOLVENT EXTRACTION;

DRUG-INDUCED LIVER INJURY; HUMANS; INFLAMMATION; KAVA;

PIPER METHYSTICUM;

EID: 79953204321     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.3301     Document Type: Article

References (20)

1. Barnes J, Anderson LA, Phillipson JD,. 2007. Herbal Medicines, 3rd edn. Pharmaceutical Press: London.
2. Clayton NP, Yoshizawa K, Kissling GE, Burka LT, Chan P-C, Nyska A,. 2007. Immunohistochemical analysis of expressions of hepatic cytochrome P450 in F344 rats following oral treatment with kava extract. Exp Toxicol Pathol 58: 223-236. (Pubitemid 44873076)
3. Currie BJ, Clough AR,. 2003. Kava hepatotoxicity with Western herbal products: does it occur with traditional kava use? Med J Austr 178: 421-422. (Pubitemid 36591911)
4. Dragull K, Yoshida WY, Tang C-S., 2003. Piperidine alkaloids from Piper methysticum. Phytochemistry 63: 193-198. (Pubitemid 36560138)
5. Duffield AM, Jamieson DD, Lidgard RO, Duffield PH, Bourne DJ,. 1989. Identification of some human urinary metabolites of the intoxicating beverage kava. J Chromatogr A 475: 273-281. (Pubitemid 19193596)
6. Escher M, Desmeules J, Giostra E, Mentha G,. 2001. Hepatitis associated with Kava, a herbal remedy for anxiety. Br Med J 322: 139. (Pubitemid 32116192)
7. Fu S, Korkmaz E, Braet F, Ngo Q, Ramzan I,. 2008. Influence of kavain on hepatic ultrastructure. World J Gastroenterol 14: 541-546. (Pubitemid 351320819)
8. Gow PJ, Connelly NJ, Hill RL, Crowley P, Angus PW,. 2003. Fatal fulminant hepatic failure induced by a natural therapy containing kava. Med J Austr 178: 442-443. (Pubitemid 36591919)
9. Ingelman-Sundberg M,. 2004. Genetic polymorphisms of cytochrome P450 2D6 (CYP2D6): Clinical consequences, evolutionary aspects and functional diversity. Pharmacogenomics J 5: 6-13. (Pubitemid 40220611)
10. Jhoo JW, Freeman JP, Heinze TM, et al. 2006. In vitro cytotoxicity of nonpolar constituents from different parts of kava plant (Piper methysticum). J Agric Food Chem 54: 3157-3162.
11. Johnson BM, Qiu S-X, Zhang S, et al. 2003. Identification of novel electrophilic metabolites of Piper methysticum Forst. (Kava). Chem Res Toxicol 16: 733-740. (Pubitemid 36736604)
12. Lude S, Torok M, Dieterle S, Jaggi R, Buter KB, Krahenbuhl S,. 2008. Hepatocellular toxicity of kava leaf and root extracts. Phytomedicine 15: 120-131. (Pubitemid 350297905)
13. Roberts RA, Ganey PE, Ju C, Kamendulis LM, Rusyn I, Klaunig JE,. 2007. Role of the kupffer cell in mediating hepatic toxicity and carcinogenesis. Toxicol Sci 96: 2-15. (Pubitemid 46323203)
14. Russmann S, Lauterburg BH, Helbling A,. 2001. Kava hepatotoxicity. Ann Intern Med 135: 68-69.
15. Sarris J, Kavanagh DJ,. 2009. Kava and St John's Wort: current evidence for use in mood and anxiety disorders. J Altern Complement Med 15: 827-836.
16. Teschke R, Genthner A, Wolff A,. 2009. Kava hepatotoxicity: comparison of aqueous, ethanolic, acetonic kava extracts and kava-herbs mixtures. J Ethnopharmacol 123: 378-384.
17. Teschke R, Schwarzenboeck A, Akinci A,. 2008. Kava hepatotoxicity: a European view. N Z Med J 121: 90-98.
18. Whitton PA, Lau A, Salisbury A, Whitehouse J, Evans CS,. 2003. Kava lactones and the kava-kava controversy. Phytochemistry 64: 673-679. (Pubitemid 37176400)
19. Wu D, Yu L, Nair MG, DeWitt DL, Ramsewak RS., 2002. Cyclooxygenase enzyme inhibitory compounds with antioxidant activities from Piper methysticum (kava kava) roots. Phytomedicine 9: 41-47. (Pubitemid 34184208)
20. Zou L, Harkey MR, Henderson GL,. 2005. Synthesis, in vitro reactivity, and identification of 6-phenyl-3-hexen-2-one in human urine after kava-kava (Piper methysticum) ingestion. Planta Med 71: 142-146. (Pubitemid 40363557)